Literature DB >> 3552993

Metabolism of Mycobacterium leprae in macrophages.

N Ramasesh, R C Hastings, J L Krahenbuhl.   

Abstract

The incorporation of 14C-labeled palmitic acid ( [U-14C]PA) into the phenolic glycolipid-I (PGL-I) fraction of Mycobacterium leprae was studied in a murine macrophage system in vitro. Peritoneal macrophages from Swiss Webster mice were infected with fresh viable or Formalin-killed M. leprae harvested from infected footpads of nu/nu mice, and [U-14C]PA was added to the culture medium. Labeled glycolipid synthesized by live M. leprae was fractionated on a Florisil-silicic acid column and identified as PGL-I by using thin-layer chromatography and localization on a polysulfone membrane with an anti-PGL-I monoclonal antibody. Increased incorporation of [U-14C]PA into the PGL-I fraction was observed in macrophages infected with only live M. leprae. Treatment of the infected macrophages with rifampin caused a significant reduction in the incorporation of palmitic acid into PGL-I. These preliminary studies suggest that PGL-I synthesis can be used to quantitate the metabolism of M. leprae in macrophages in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552993      PMCID: PMC260491          DOI: 10.1128/iai.55.5.1203-1206.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Incorporation of tritiated thymidine by leprosy bacilli in cultures of human lepromatous macrophages.

Authors:  D J Drutz; M J Cline
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Rifampicin: a new rifamycin. I. Bacteriological studies.

Authors:  V Arioli; R Pallanza; S Furesz; G Carniti
Journal:  Arzneimittelforschung       Date:  1967-05

4.  The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Authors:  G Hartmann; K O Honikel; F Knüsel; J Nüesch
Journal:  Biochim Biophys Acta       Date:  1967

5.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

6.  Studies on M. lepraemurium and M. leprae in tissue culture.

Authors:  E W Garbutt
Journal:  Int J Lepr       Date:  1965 Jul-Sep

7.  Studies of the mouse foot pad technique for cultivation of Mycobacterium leprae. 3. Doubling time during logarithmic multiplication.

Authors:  L Levy
Journal:  Lepr Rev       Date:  1976-06       Impact factor: 0.537

8.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

9.  Evidence for species-specific lipid antigens in Mycobacterium leprae.

Authors:  P J Brennan; W W Barrow
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-12

10.  The uptake of 3H-thymidine in Mycobacterium leprae inoculated mouse macrophage cultures as a rapid indicator of bacillary viability. Factors influencing the specificity of the in vitro assay.

Authors:  M Sathish; I Nath
Journal:  Int J Lepr Other Mycobact Dis       Date:  1981-06
View more
  8 in total

1.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 2.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

Review 3.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.

Authors:  N Ramasesh; J L Krahenbuhl; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.

Authors:  Y Mistry; N H Antia; R Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Biophysical optima for metabolism of Mycobacterium leprae.

Authors:  S G Franzblau; E B Harris
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

7.  Effects of activated macrophages on Mycobacterium leprae.

Authors:  N Ramasesh; L B Adams; S G Franzblau; J L Krahenbuhl
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.

Authors:  Grace L Davis; Nashone A Ray; Ramanuj Lahiri; Thomas P Gillis; James L Krahenbuhl; Diana L Williams; Linda B Adams
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.